Search results

1. Mesenchymal stem cells as potential immunosuppression in skeletal muscle cell therapy - studies in a mouse model

Principal investigator: dr Barbara Anna Świerczek

Uniwersytet Warszawski, Wydział Biologii

Call: PRELUDIUM 12, Panel: NZ6

2. Where Inhibition is not Enough- Development of Innovative Compounds for Targeted Degradation of Extracellular and Membra…

Principal investigator: dr Marcin Skoreński

Politechnika Wrocławska

Call: OPUS 28 (LAP), Panel: NZ5

3. Dual cell cycle blockade and immune checkpoint inhibition as a potential strategy of sequential anticancer therapy

Principal investigator: Alicja Stanisława Słota

Uniwersytet Jagielloński

Call: PRELUDIUM 24, Panel: NZ7

4. Molecular Pathogenesis and Precision Antisense Oligonucleotide Therapy for BAG3-Related Myofibrillar Myopathy Type 6 Usi…

Principal investigator: dr Estera Elmira Rintz

Uniwersytet Gdański

Call: OPUS 29, Panel: NZ2

5. Strategies to improve the efficacy of NK cells in targeting aggressive B-cell lymphomas

Principal investigator: dr Małgorzata Bobrowicz

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: WEAVE-UNISONO, Panel: NZ6

6. Bioconjugates of multimodal nanoparticles for targeted alpha and hyperthermia therapy. Synthesis, retention studies of r…

Principal investigator: Edyta Cędrowska

Instytut Chemii i Techniki Jądrowej

Call: PRELUDIUM 9, Panel: ST4

7. Combination therapy with naphthoquinones and paclitaxel in the pharmacological induction of cell death in breast cancer …

Principal investigator: dr Anna Kawiak

Uniwersytet Gdański

Call: OPUS 2, Panel: NZ7

8. Understanding of human insulin maturation for cell and gene therapy in diabetes

Principal investigator: dr hab. Małgorzata Borowiak

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

Call: OPUS 19, Panel: NZ3

9. Cell replacement therapy for restoring motor function in paraplegic rats - selective activation of serotonergic neurons …

Principal investigator: prof. Urszula Sławińska

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

Call: OPUS 5, Panel: NZ4

10. Chronic pain in obesity: from cellular mechanisms to new strategies for targeted therapy.

Principal investigator: dr Anna Piotrowska-Murzyn

Instytut Farmakologii PAN

Call: SONATA 17, Panel: NZ5

11. Development of an innovative method of preparing iPS cells for gene-cell therapy of hereditary diseases based on the Ost…

Principal investigator: dr Agnieszka Karolina Fus-Kujawa

Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Medycznych w Katowicach

Call: PRELUDIUM 19, Panel: NZ2

12. Synthesis and characterization of antioxidant chitosan hydrogels doped with carbon quantum dots applicable in cell thera…

Principal investigator: Łukasz Piotr Janus

Politechnika Krakowska im. Tadeusza Kościuszki, Wydział Inżynierii i Technologii Chemicznej

Call: PRELUDIUM 13, Panel: ST8

13. The importance of interaction between NMDA and AMPA receptors and scaffolding proteins in the excitatory synaptic in the…

Principal investigator: dr hab. Magdalena Jolanta Sowa-Kućma

Uniwersytet Rzeszowski, Kolegium Nauk Medycznych

Call: OPUS 11, Panel: NZ7

14. New approach to glioblastoma adoptive therapy based on inducible CAR expression system - SynCAR

Principal investigator: dr hab. Radosław Zagożdżon

Warszawski Uniwersytet Medyczny

Call: OPUS 29, Panel: NZ6

15. Proline metabolism as a novel therapeutic target for diseases associated with mitochondrial dysfunction.

Principal investigator: dr Karolina Szczepanowska

Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

Call: SONATA BIS 11, Panel: NZ3

16. Personalized selective activation of γδT Vδ2 cells using zoledronic acid for glioblastoma MICA/Bhigh therapy: in vitro a…

Principal investigator: Natalia Anna Lehman

Uniwersytet Medyczny w Lublinie

Call: PRELUDIUM 24, Panel: NZ4

17. Reversible senescence as a new mechanism of cancer cell resistance for chemotherapy. Analysis of the mechanism of cancer…

Principal investigator: dr Karolina Anna Staniak

Politechnika Warszawska, Wydział Chemiczny

Call: SONATINA 5, Panel: NZ3

18. Mesenchymal stromal cells (MSC) as carriers of IL-12 cDNA in treatment of mice with melanoma B16-F10 and metastases

Principal investigator: Natalia Iwona Kułach

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

Call: PRELUDIUM 9, Panel: NZ4

19. Next-Generation Exosome Therapy: Engineering NK Cell-Derived Vesicles for Targeted Cancer Treatment

Principal investigator: dr Daria Nawrocka

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: SONATINA 9, Panel: NZ6

20. Elimination of IgE-producing cells using next-generation chimeric antigen receptor (CAR)-based therapy

Principal investigator: dr hab. Beata Kaleta

Warszawski Uniwersytet Medyczny

Call: OPUS 29, Panel: NZ6

21. Precision double strike against non-small cell lung cancer. Insights into multidirectional therapies and the landscape o…

Principal investigator: dr Katarzyna Anna Malarz

Politechnika Śląska

Call: OPUS 27, Panel: NZ5

22. Cuproptosis, a novel pathway of regulated cell death as a therapeutic target in treatment-naïve and targeted therapy-res…

Principal investigator: dr hab. Mariusz Łukasz Hartman

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Call: OPUS 25, Panel: NZ5

23. Unveiling the molecular signature underlying resistance to CD19 CAR-T therapy in malignant cells.

Principal investigator: Marta Krawczyk

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: PRELUDIUM 22, Panel: NZ7

24. MicroRNAs in blood as biomarkers for Alzheimer's disease: molecular signature for personalized therapy

Principal investigator: prof. Urszula Wojda

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

Call: OPUS 15, Panel: NZ7

25. From a molecular in silico model to cellular response in vitro. Modified nucleosides as photo and/or radiosensitizers of…

Principal investigator: prof. Janusz Adam Rak

Uniwersytet Gdański, Wydział Chemii

Call: MAESTRO 6, Panel: ST4

26. Characteristics of the cell wall hydrolases of pathogenic bacteria Listeria monocytogenes and their partcipation in the …

Principal investigator: dr hab. Magdalena Anna Popowska

Uniwersytet Warszawski, Wydział Biologii

Call: OPUS 5, Panel: NZ6

27. Canonical and non-canonical roles of DDK in oncogenesis: a cornerstone for the development of novel, potent anticancer t…

Principal investigator: dr Jan Marian Suski

Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

Call: SONATA BIS 14, Panel: NZ3

28. Identification and characterization of novel players in HIV-1 RNA nuclear processing and export to dissect post-transcri…

Principal investigator: dr hab. Anna Kula-Pacurar

Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

Call: OPUS 23, Panel: NZ3

29. Molecular and cellular landscape of pulmonary and hepatic metastases of colorectal cancer with potential clinical implic…

Principal investigator: dr Marta Aleksandra Popęda

Gdański Uniwersytet Medyczny, Wydział Lekarski

Call: PRELUDIUM 20, Panel: NZ4

30. Characterization of anticancer activity of new synthetic alpha-methylene-delta lactones in cancer cell lines.

Principal investigator: dr hab. Katarzyna Anna Gach-Janczak

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Call: SONATA 9, Panel: NZ3

31. Cellular and molecular mechanism of action of PPI dendrimer complexes with nucleoside analogue anticancer drugs

Principal investigator: prof. Barbara Teresa Klajnert-Maculewicz

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Call: OPUS 7, Panel: NZ3

32. The interplay of neurochemistry and cancer biology: in the search for novel glioblastoma multiforme therapy among dopami…

Principal investigator: dr Katarzyna Maria Kucwaj-Brysz

Uniwersytet Jagielloński, Collegium Medicum

Call: SONATA 17, Panel: NZ7

33. Investigation of the MLK4 biology in breast cancer and search for new therapeutic strategies using innovative PROTAC com…

Principal investigator: dr Anna Agnieszka Marusiak

Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

Call: SONATA BIS 11, Panel: NZ5

34. MicroRNAome maturation control and its application in selective targeting of cancer stem cells

Principal investigator: dr Jakub Godlewski

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: OPUS 20, Panel: NZ5

35. Immune response induced by injection-oral co-immunisation with plant-derived HBV antigens polarising the response to Th1…

Principal investigator: prof. Tomasz Jan Pniewski

Instytut Genetyki Roślin PAN

Call: OPUS 19, Panel: NZ6

36. Synthetic analogues of opioid growth factor linked to derivatives of glucosamine as a potential compounds for targeted t…

Principal investigator: prof. Iwona Maria Inkielewicz-Stępniak

Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

Call: OPUS 18, Panel: NZ7

37. Cellular mechanisms and effects in vivo of selective lactate dehydrogenase A inhibitors in experimental models of mesoth…

Principal investigator: prof. Ryszard Tomasz Smoleński

Gdański Uniwersytet Medyczny, Wydział Lekarski

Call: OPUS 16, Panel: NZ7

38. Inhibition of tyrosine phosphatase as a strategy to enhance insulin sensitivity through activation of chaperone mediated…

Principal investigator: dr hab. Krzysztof Marycz

Uniwersytet Przyrodniczy we Wrocławiu, Wydział Biologii i Hodowli Zwierząt

Call: OPUS 15, Panel: NZ7

39. Combined urinary bladder cancer treatment with isothiocyanate-derived mercapturic acids and microtubule assembly modulat…

Principal investigator: dr Mateusz Psurski

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: SONATA 13, Panel: NZ7

40. Effectiveness of anticancer activity of DMU-214 (3'-hydroxy-3,4,5,4'-tetrametoxystilbene) in personalized treatment for …

Principal investigator: dr hab. Hanna Helena Piotrowska-Kempisty

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Call: SONATA 12, Panel: NZ7

41. Chemically modified mRNA for studies on cellular processes and therapeutic applications

Principal investigator: prof. Jacek Jemielity

Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

Call: OPUS 11, Panel: ST5

42. Role of the selected anti-tumor agents transported by electropermeabilization to the drug-sensitive and drug-resistant c…

Principal investigator: dr Joanna Barbara Weżgowiec

Politechnika Wrocławska, Wydział Podstawowych Problemów Techniki

Call: PRELUDIUM 8, Panel: NZ7

43. Miniature CRISPR/Cas nucleases for upregulation of utrophin expression: a novel approach for mutation-independent therap…

Principal investigator: prof. Józef Dulak

Uniwersytet Jagielloński

Call: DAINA 3, Panel: NZ3

44. Molecular and physiological mechanism of activity of biodegradable cell scaffolds based on an electrospun polymer matrix…

Principal investigator: Michał Tadeusz Pruchniewski

Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Biologii

Call: PRELUDIUM 22, Panel: NZ4

45. Tunneling nanotubes (TNTs) within the leukemia microenvironment; influence of metabolic remodeling and implications for …

Principal investigator: dr hab. Katarzyna Piwocka

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

Call: OPUS 15, Panel: NZ3

46. New opportunities for use of PERK kinase inhibitors in eIF2alfa factor-dependant signalling pathway in antitumor therapy

Principal investigator: dr Wioletta Julia Rozpędek-Kamińska

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Call: PRELUDIUM 10, Panel: NZ3

47. Does overexpression of cell adhesion molecule L1 in rats with complete spinal cord transection influences the expression…

Principal investigator: dr Rafał Krzysztof Płatek

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

Call: PRELUDIUM 3, Panel: NZ4

48. Atypical antipsychotic drugs effects on pro-and antioxidative processes, and apoptosis - a study in blood cells, plasma,…

Principal investigator: dr hab. Anna Dietrich-Muszalska

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Call: OPUS 1, Panel: NZ4

49. EBI2 receptor as a new myelin repair therapy in multiple sclerosis.

Principal investigator: dr hab. Aleksandra Rutkowska

Gdański Uniwersytet Medyczny, Wydział Lekarski

Call: SONATA 18, Panel: NZ3

50. Analiza zmian architekturalnych jądra komórkowego neuronów i astrocytów w eksperymentalnych modelach stresu i depresji.

Principal investigator: Katarzyna Karolina Pels

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

Call: ETIUDA 7, Panel: NZ4

Projects search